scispace - formally typeset
P

Pascal De Tullio

Researcher at University of Liège

Publications -  128
Citations -  2442

Pascal De Tullio is an academic researcher from University of Liège. The author has contributed to research in topics: Benzothiadiazine & AMPA receptor. The author has an hindex of 26, co-authored 122 publications receiving 2106 citations. Previous affiliations of Pascal De Tullio include Université libre de Bruxelles.

Papers
More filters
Journal ArticleDOI

Chloro-substituted 3-alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel activators: impact of the position of the chlorine atom on the aromatic ring on activity and tissue selectivity.

TL;DR: 6-chloro-3-alkylamino/cycloalkylaminos-4H-1,2,4-benzothiadiazine 1,1-dioxides appear to be more attractive than their previously described 7- chloro-substituted analogues as original drugs activating the SUR1/Kir6.2 K(ATP) channels.
Journal ArticleDOI

KATP channel openers: tissue selectivity of original 3-alkylaminopyrido- and 3-alkylaminobenzothiadiazine 1,1-dioxides.

TL;DR: Radioisotopic, electrophysiological and pharmacological investigations indicate that the marked vasorelaxant properties of the 3-alkylaminobenzothiadiazine 1,1-dioxides are related to the activation of smooth muscle K(ATP) channels.
Journal ArticleDOI

Hydroxylated analogues of ATP-sensitive potassium channel openers belonging to the group of 6- and/or 7-substituted 3-Isopropylamino-4H-1,2,4- benzothiadiazine 1,1-dioxides: Toward an improvement in sulfonylurea receptor 1 selectivity and metabolism stability

TL;DR: One of the most potent and SUR1-selective enantiomers, (R)-7-chloro-3-(1-hydroxy-2-propyl)amino-4H-1,2,4-benzothiadiazine 1,1-dioxide 13a, can be considered as a new lead candidate displaying improved physicochemical and pharmacological properties as well as improved metabolic stability compared to its nonhydroxylated counterpart, 1a.
Journal ArticleDOI

Synthesis and activity on rat aorta rings and rat pancreatic beta-cells of ring-opened analogues of benzopyran-type potassium channel activators.

TL;DR: Ring-opened analogues of dihydrobenzopyran potassium channel openers were prepared and evaluated as putative PCOs on rat aorta rings (myorelaxant effect) and rat pancreatic beta-cells (inhibition of insulin secretion).